Nuria Lacuey1, Bilal Zonjy2, Johnson P Hampson1, M R Sandhya Rani2, Anita Zaremba2, Rup K Sainju2,3, Brian K Gehlbach2,3, Stephan Schuele2,4, Daniel Friedman2,5, Orrin Devinsky2,5, Maromi Nei2,6, Ronald M Harper2,7, Luke Allen2,8, Beate Diehl2,8, John J Millichap2,9, Lisa Bateman2,10, Mark A Granner2, Deidre N Dragon2, George B Richerson2,3, Samden D Lhatoo1,2. 1. Epilepsy Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA. 2. NINDS Center for SUDEP Research (CSR), Cleveland, OH, USA. 3. University of Iowa School of Medicine, Iowa City, IA, USA. 4. Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. 5. NYU Langone School of Medicine, New York, NY, USA. 6. Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA. 7. Department of Neurobiology and the Brain Research Institute, University of California, Los Angeles (UCLA), Los Angeles, CA, USA. 8. Institute of Neurology, University College London, London, UK. 9. Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA. 10. Department of Neurology, Columbia University, New York, NY, USA.
Abstract
OBJECTIVE: The aim of this study was to investigate periictal central apnea as a seizure semiological feature, its localizing value, and possible relationship with sudden unexpected death in epilepsy (SUDEP) pathomechanisms. METHODS: We prospectively studied polygraphic physiological responses, including inductance plethysmography, peripheral capillary oxygen saturation (SpO2 ), electrocardiography, and video electroencephalography (VEEG) in 473 patients in a multicenter study of SUDEP. Seizures were classified according to the International League Against Epilepsy (ILAE) 2017 seizure classification based on the most prominent clinical signs during VEEG. The putative epileptogenic zone was defined based on clinical history, seizure semiology, neuroimaging, and EEG. RESULTS: Complete datasets were available in 126 patients in 312 seizures. Ictal central apnea (ICA) occurred exclusively in focal epilepsy (51/109 patients [47%] and 103/312 seizures [36.5%]) (P < .001). ICA was the only clinical manifestation in 16/103 (16.5%) seizures, and preceded EEG seizure onset by 8 ± 4.9 s, in 56/103 (54.3%) seizures. ICA ≥60 s was associated with severe hypoxemia (SpO2 <75%). Focal onset impaired awareness (FOIA) motor onset with automatisms and FOA nonmotor onset semiologies were associated with ICA presence (P < .001), ICA duration (P = .002), and moderate/severe hypoxemia (P = .04). Temporal lobe epilepsy was highly associated with ICA in comparison to extratemporal epilepsy (P = .001) and frontal lobe epilepsy (P = .001). Isolated postictal central apnea was not seen; in 3/103 seizures (3%), ICA persisted into the postictal period. SIGNIFICANCE: ICA is a frequent, self-limiting semiological feature of focal epilepsy, often starting before surface EEG onset, and may be the only clinical manifestation of focal seizures. However, prolonged ICA (≥60 s) is associated with severe hypoxemia and may be a potential SUDEP biomarker. ICA is more frequently seen in temporal than extratemporal seizures, and in typical temporal seizure semiologies. ICA rarely persists after seizure end. ICA agnosia is typical, and thus it may remain unrecognized without polygraphic measurements that include breathing parameters. Wiley Periodicals, Inc.
OBJECTIVE: The aim of this study was to investigate periictal central apnea as a seizure semiological feature, its localizing value, and possible relationship with sudden unexpected death in epilepsy (SUDEP) pathomechanisms. METHODS: We prospectively studied polygraphic physiological responses, including inductance plethysmography, peripheral capillary oxygen saturation (SpO2 ), electrocardiography, and video electroencephalography (VEEG) in 473 patientsin a multicenter study of SUDEP. Seizures were classified according to the International League Against Epilepsy (ILAE) 2017 seizure classification based on the most prominent clinical signs during VEEG. The putative epileptogenic zone was defined based on clinical history, seizure semiology, neuroimaging, and EEG. RESULTS: Complete datasets were available in 126 patients in 312 seizures. Ictal central apnea (ICA) occurred exclusively in focal epilepsy (51/109 patients [47%] and 103/312 seizures [36.5%]) (P < .001). ICA was the only clinical manifestation in 16/103 (16.5%) seizures, and preceded EEG seizure onset by 8 ± 4.9 s, in 56/103 (54.3%) seizures. ICA ≥60 s was associated with severe hypoxemia (SpO2 <75%). Focal onset impaired awareness (FOIA) motor onset with automatisms and FOA nonmotor onset semiologies were associated with ICA presence (P < .001), ICA duration (P = .002), and moderate/severe hypoxemia (P = .04). Temporal lobe epilepsy was highly associated with ICA in comparison to extratemporal epilepsy (P = .001) and frontal lobe epilepsy (P = .001). Isolated postictal central apnea was not seen; in 3/103 seizures (3%), ICA persisted into the postictal period. SIGNIFICANCE: ICA is a frequent, self-limiting semiological feature of focal epilepsy, often starting before surface EEG onset, and may be the only clinical manifestation of focal seizures. However, prolonged ICA (≥60 s) is associated with severe hypoxemia and may be a potential SUDEP biomarker. ICA is more frequently seen in temporal than extratemporal seizures, and in typical temporal seizure semiologies. ICA rarely persists after seizure end. ICA agnosia is typical, and thus it may remain unrecognized without polygraphic measurements that include breathing parameters. Wiley Periodicals, Inc.
Authors: Stephan U Schuele; Mitra Afshari; Zahra S Afshari; Michael P Macken; Jorge Asconape; Lisa Wolfe; Elizabeth E Gerard Journal: Epilepsy Behav Date: 2011-08-04 Impact factor: 2.937
Authors: Dale C Hesdorffer; Torbjorn Tomson; Emma Benn; Josemir W Sander; Lena Nilsson; Yvonne Langan; Thaddeus S Walczak; Ettore Beghi; Martin J Brodie; Allen Hauser Journal: Epilepsia Date: 2011-01-28 Impact factor: 5.864
Authors: Philippe Ryvlin; Lina Nashef; Samden D Lhatoo; Lisa M Bateman; Jonathan Bird; Andrew Bleasel; Paul Boon; Arielle Crespel; Barbara A Dworetzky; Hans Høgenhaven; Holger Lerche; Louis Maillard; Michael P Malter; Cecile Marchal; Jagarlapudi M K Murthy; Michael Nitsche; Ekaterina Pataraia; Terje Rabben; Sylvain Rheims; Bernard Sadzot; Andreas Schulze-Bonhage; Masud Seyal; Elson L So; Mark Spitz; Anna Szucs; Meng Tan; James X Tao; Torbjörn Tomson Journal: Lancet Neurol Date: 2013-09-04 Impact factor: 44.182
Authors: A S Blum; J R Ives; A L Goldberger; I C Al-Aweel; K B Krishnamurthy; F W Drislane; D L Schomer Journal: Epilepsia Date: 2000-05 Impact factor: 5.864
Authors: Brian J Dlouhy; Brian K Gehlbach; Collin J Kreple; Hiroto Kawasaki; Hiroyuki Oya; Colin Buzza; Mark A Granner; Michael J Welsh; Matthew A Howard; John A Wemmie; George B Richerson Journal: J Neurosci Date: 2015-07-15 Impact factor: 6.167
Authors: Christoph Baumgartner; Johannes Koren; Martha Britto-Arias; Simone Schmidt; Susanne Pirker Journal: Clin Auton Res Date: 2019-02-25 Impact factor: 4.435
Authors: Arun Murugesan; M R Sandhya Rani; Laura Vilella; Nuria Lacuey; Johnson P Hampson; Carl L Faingold; Daniel Friedman; Orrin Devinsky; Rup K Sainju; Stephan Schuele; Beate Diehl; Maromi Nei; Ronald M Harper; Lisa M Bateman; George Richerson; Samden D Lhatoo Journal: Neurology Date: 2019-09-04 Impact factor: 9.910
Authors: Brian K Gehlbach; Rup K Sainju; Deanne K Tadlock; Deidre N Dragon; Mark A Granner; George B Richerson Journal: Epilepsy Behav Date: 2018-06-30 Impact factor: 2.937
Authors: William P Nobis; Karina A González Otárula; Jessica W Templer; Elizabeth E Gerard; Stephen VanHaerents; Gregory Lane; Guangyu Zhou; Joshua M Rosenow; Christina Zelano; Stephan Schuele Journal: J Neurosurg Date: 2019-04-05 Impact factor: 5.115
Authors: Nuria Lacuey; Rita Martins; Laura Vilella; Johnson P Hampson; M R Sandhya Rani; Kingman Strohl; Anita Zaremba; Jaison S Hampson; Rup K Sainju; Daniel Friedman; Maromi Nei; Catherine Scott; Brian K Gehlbach; Norma J Hupp; Stephan Schuele; Jennifer Ogren; Ronald M Harper; Luke Allen; Beate Diehl; Lisa M Bateman; Orrin Devinsky; George B Richerson; Samden Lhatoo Journal: Epilepsy Behav Date: 2019-07-10 Impact factor: 2.937
Authors: S Patodia; M Tachrount; A Somani; I Scheffer; T Yousry; X Golay; S M Sisodiya; M Thom Journal: Neuropathol Appl Neurobiol Date: 2020-07-15 Impact factor: 8.090